Articles with public access mandates - Arnav Agarwal - Swiss Cancer LeagueLearn more
NoteFor this mandate, articles should be available from specific locations.
OverallNIHRCIHRMRCNIHAcademy of FinlandYorkshire Cancer Research, UKDFIDSNSFWellcomeNSERCBHFNHMRCArnold Ventures LLCPancreatic Cancer, UKVACancer Research UKGatesFRQSMTAEuropean CommissionGovernment of SpainSCLNSFCDMTWHOUK Research & InnovationHSFSSHRCDNRFDSTFCTCSOESRCNRFState of CalifoniaBMBFNKFIResearch Grants Council, Hong KongDamon Runyon Cancer Research FoundationHealth Data Research, UK
Available based on mandate: 3
Clinical trial evidence supporting US Food and Drug Administration approval of novel cancer therapies between 2000 and 2016
A Ladanie, AM Schmitt, B Speich, F Naudet, A Agarwal, TV Pereira, ...
JAMA network open 3 (11), e2024406-e2024406, 2020
Single pivotal trials with few corroborating characteristics were used for FDA approval of cancer therapies
A Ladanie, B Speich, M Briel, F Sclafani, HC Bucher, A Agarwal, ...
Journal of clinical epidemiology 114, 49-59, 2019
The Comparative Effectiveness of Innovative Treatments for Cancer (CEIT-Cancer) project: Rationale and design of the database and the collection of evidence available at …
A Ladanie, B Speich, F Naudet, A Agarwal, TV Pereira, F Sclafani, ...
Trials 19, 1-13, 2018
Publication and funding information is determined automatically by a computer program